Nomura Holdings Inc Aerie Pharmaceuticals Inc Transaction History

Nomura Holdings Inc

  • $41.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
BUY
$6.37 - $15.23 $298,708 - $714,180
46,893 New
46,893 $709,000
Q1 2020

May 14, 2020
SELL
$11.84 - $25.52 $170,496 - $367,488
-14,400 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$17.72 - $25.1 $255,167 - $361,440
14,400 New
14,400 $347,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email